tirzepatide/cyano b12 Tirzepatide/Glycine/B12 Tirzepatide (Month 1) 2.5mg |
Description
Avoid high-fat meals in the first few days, as fat slows gastric emptying further and can compound the effect of tirzepatide on stomach motility

Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management and chronic weight management
Persistent nausea that does not improve after the first few weeks

Factors including genetics, baseline metabolic status, dietary patterns, activity levels, and medication adherence all influence results
Your shipment includes a per-vial unit conversion table for safety

Please talk to a healthcare provider if you experience fatigue for an extended period
